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Tuberculosis is the leading cause of infectious disease in Nepal. An estimated 60% of the 
adult population aged between 15-45 years is infected with tuberculosis, and 45% of the total 
population is infected. Ten percent of people infected with TB progress to active disease. To 
combat tuberculosis, Directly Observed Therapy (DOT) was adopted in Nepal in 1996. DOT 
was administered at four national demonstration sites in 1996 and expanded over time so that 
56% of the population to date have been covered by DOT. This study aimed to evaluate DOT in 
pulmonary TB patients in Nepal in terms of patient outcome and compliance. DOT was 
compared against a conventional treatment program or self-administered therapy (SAT), which 
served as the control group. The project was a retrospective nonconcurrant cohort study. 
Patients were sputum positive pulmonary TB patients aged over 15 years from Bhaktapur district 
in Nepal, who had undergone DOT or SAT between 1996 and 1998. Medical records of all the 
patients were sent to the National TB Center in Thimi, Nepal. A total of 261 patients (DOT, 161 
patients and SAT, 100 patients) were included in the study. The two groups were similar in 
terms of age, ethnicity, and religion status. The cure rate was 86.3% for DOT, which was 
significantly higher than the 75.0% for the SAT group (p<0.05). The compliance rate was also 
higher for DOT at 90.2% versus 81.8% for the SAT group (p<0.05). The mean treatment length 
was 6.8 months for the SAT group and 7.4 months for the DOT group (p<0.05). 
Higher rates of treatment compliance and cure rate were achieved in the DOT group versus the 
SAT group. Thus, DOT is advocated as a means of ensuring greater TB program success. 
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CHAPTER 1 
Introduction 
Tuberculosis (TB) is a major infectious disease infecting over one third of the world's 
population. The World Health Organization (WHO) estimates that 8 million of these infected 
individuals develop active TB and two million die each year. WHO declared TB a global 
emergency in April 1993. The reasons for this resurgence include the emergence of ADDS, 
homelessness, an increase in multi-drug resistant cases, and the failure of many national TB 
control programs (World Health Organization [WHO], 2000). 
TB is now the leading cause of infectious disease in Nepal. An estimated 60% of the adult 
population aged between 15-45 years are infected with tuberculosis, and 45% of the total 
population are infected. Ten percent of people infected progress to active disease (World 
Health Organization / His Majesty's Government of Nepal [WHO/HMG] Review, 1994). 
This review found a case detection rate of 30% and a cure rate of only 40%. The review 
team recommended that His Maj esty' s Government (HMG) of Nepal change the National TB 
Control Program (NTP) strategy to achieve better results. As a result, the Directly Observed 
Therapy (DOT) strategy was adopted in Nepal with the approval of a 5-year development 
plan in 1995. Four national demonstration and training districts for DOT were established in 
1996. On the basis of encouraging results of these districts, DOT is being expanded over time 
to cover the entire population by the year 2003. To date, 52 out of 75 districts with 56% of 
the population have been covered by DOT in Nepal (Bam, 2000). It remains to be seen 
whether DOT in Nepal, implemented since 1996, will be able to achieve 
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the WHO goals of an 85% cure rate in new sputum positive cases and a 70% case detection 
rate among existing TB cases (WHO, 2000). 
Purpose of the study 
The purpose of this study was to evaluate Directly Observed Therapy in pulmonary TB 
cases in Nepal. The researcher attempted to answer the following questions. What is the rate 
of patients on DOT who complete the therapy as compared to TB patients getting self-
administered therapy (SAT)? What is the cure rate for patients with TB who receive DOT as 
compared to TB patients getting self-administered therapy? The effectiveness of DOT was 
compared against a conventional treatment program (self-administered therapy), which served 
as the comparison group. The study also aimed to examine the attitude of providers towards 
the effectiveness and administration of DOT. 
Need for the study 
With the high prevalence and incidence of cases, Nepal desperately needs an effective TB 
intervention program. Directly Observed Therapy has proven to be an effective solution in 
other parts of the world. But for any intervention to be successful there has to be local 
evaluations and constant feedback to the program. Thus, the needs for this study are as 
follows: (1) comparing the effectiveness of DOT with a conventional treatment program, (2) 
measuring the attitudes of the providers towards the programs' effectiveness and 
implementation, and (3) understanding the causes behind success or failure of the program. 
The study results will be useful to the health policy planners, donor agencies, and health 
care providers in Nepal. If the study determines that DOT has made a significant impact in 
increasing patient compliance, that finding will have a positive effect on all concerned with TB 
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prevention in Nepal. 
Hypotheses 
The following hypotheses were tested: 
1) There will be no difference in patient compliance between patients receiving DOT versus 
those receiving self-administered therapy; 
2) There will be no difference in treatment success rates between patients receiving DOT 
versus those receiving self-administered therapy. 
Delimitations 
This study was delimited to active TB cases attending TB clinics in the district of 
Bhaktapur, Nepal. One group of patients received DOT and the second group received 
conventional treatment. In the DOT group, all the patients had undergone treatment between 
1997-1998. In the SAT group, patients had undergone treatment between 1996 and 1999. 
Limitations 
1) Since the study was retrospective and depended upon clinic records, attrition and accuracy 
of reporting may have been a significant problem. 
2) The study group and the comparison group may not be equivalent due to self-selection into 
treatment centers. 
3) Generalizability of the results was limited as the study only focused on TB patients in one 
district. 
Assumptions 
1) The providers were honest in answering the questionnaire. 
4 
2) The information provided in the medical records was accurate. 
Definitions 
Tuberculosis- A chronic, infectious disease caused by bacteria Mycobacterium Tuberculosis 
that affects primarily the lung but can involve any organ of the body. The Acid Fast Bacilli 
(AFB) test is an inexpensive and effective test to determine the presence of the bacteria in the 
sputum. This study included only patients with pulmonary tuberculosis who were sputum 
positive or active cases. 
Patient outcome was divided into the following categories: 
Transfer out- referred to formal referral, following diagnosis, of patients living in neighboring 
districts to their own districtas health center for continuation of treatment. 
Death- fatality while patient compliant with treatment. 
Treatment discontinued- referred to patient initiated discontinuation of treatment, and a 
patient was so classified if 4 weeks of treatment was missed. 
Treatment completion- documented proof of taking every dose of a full six month treatment 
under direct supervision. 
Cured- Documented proof of treatment completion as well as sputum conversion from 
positive to negative. 
Treatment failure- In spite of treatment for 5 months, patient still producing positive sputum 
and failure to record clinical improvement. 
The following registration categories were used: 
New - If the treatment received before was none or less than 4 weeks. 
Relapse - Previously treated tuberculosis cases were classified as relapse if they become 
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sputum positive after being treated successfully. 
Return after defaulting - Interrupted treatment for more than two months and presented again 
with positive sputum smear. 
CHAPTER 2 
Review of Literature 
Nepal - An overview 
Nepal is a land-locked country bordering China on the North and India on its three other 
sides. It is a small kingdom about 500 miles long and 110 miles wide. Nepal has a total area 
covering 56,827 square miles. Though small, it is a country of physical contrasts. The 
lowlands in the south called Terai are only 200 Feet above sea level and the most fertile part 
of the country. The remaining two-thirds of the country is covered by hills and mountains. 
The north zone includes the Himalayas, with Mount Everest which is 29,028 Feet above the 
sea level, lies on Nepal's border with Tibet. 
The total population of Nepal is 22 million (1999). Hinduism is the predominant religion. 
Ninety percent of the population is Hindus, 5% are Buddhists, and about 3% are Muslims. 
Some 58 languages are in use, thus pointing out the ethnic diversity of the country although 
Nepali is the mother tongue. The population structure is typical of a less developed nation, 
with 40% of population below 15 years of age (median age, 19.9 years). 
Administratively, Nepal is divided into 5 developmental regions, 14 zones, 75 districts, 
3,913 village development committees, and 58 municipalities which include 1 metropolitan 
and 4 sub-metropolitan cities. District populations range from 5,000 in the mountains 
(Manang) to 676,000 in the terai (Morang). Nepal is one of the least developed countries of 
the world, with a per capita income of $224 (1995/1996) and 60% of the population 
estimated to be living below the poverty level. More than 90% of the population depend on 
agriculture for their livelihood. 
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Major problems faced by Nepal include overpopulation and a lack of economic 
opportunities and infrastructure. Due to the mountainous terrain most of the country is still 
inaccessible by road. As a result of the practice of logging trees for firewood, which is the 
major source of fuel energy, deforestation has wreaked havoc in terms of soil erosion and the 
loss of fertile topsoil, thus giving rise to decreased agricultural productivity. 
The Ministry of Health (MOH), a public agency, is the largest single health care provider 
in Nepal. Established in 1950, the MOH has undergone restructuring from vertical projects 
for the control of malaria, tuberculosis, leprosy, immunization, etc, to an integrated public 
health system with emphasis on preventive care (Sigdel, 1998). Each district has a 25-bed 
hospital responsible for health services to the local populace, as well as technical support to 
health posts and primary care centers. Each health post is run by a Health Assistant 
(paramedic) serving a population of 10,000-50,000. Health posts provide limited curative 
services, immunization, malaria and tuberculosis treatment, family planning activities, etc. 
Apart from Health Assistants (HA), health posts are served by Auxiliary Nurse Midwives 
(ANM) and Auxiliary Health Workers (AHW). Health posts run outreach clinics for 
immunization conducted by Village Health Workers (VHW). Kathmandu, the capital, has 
most of the tertiary and university hospitals. The distribution of health services and health 
manpower are unequal, with a greater concentration in the capital and many districts lacking 
even a single doctor. The private sector consists of private, nonprofit providers such as the 
Red Cross, United Mission to Nepal, etc. There are also many private for-profit hospitals, 
and their numbers are increasing. Traditional healers called Dhamis and Jhakris are an integral 
part of healing, especially in rural and remote villages. Appendix A contains an organizational 
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chart of the Ministry of Health. 
The health status of the Nepalese people is one of the worst in the world. The average life 
expectancy is 57.3 years (Central Bureau of Statistics [CBS], 1999). The Maternal Mortality 
Rate (MMR), 150 per 100,000 (CBS, 1999), helps account for this average. Another poor 
indicator of the population's health status is the Infant Mortality Rate, which is 75 per 1000 
live births (CBS, 1999). Infectious diseases such as diarrhea and lower respiratory infections 
including pneumonia are the major killers among infants and children. Pregnant women often 
receive no prenatal care, and deliveries in most cases are not assisted by trained health 
workers. The end result is one of the highest MMRs in the world. The high rate of poverty 
and illiteracy, lack of awareness, and inaccessibility to health care are the major reasons for 
the poor health status. Table 1 contains the most recent and accurate health and demographic 
indicators for Nepal. 
Tuberculosis 
Tuberculosis is an infectious airborne disease caused by the bacilli Mycobacterium 
Tuberculosis. It is spread by air droplets when a patient with sputum positive TB coughs, 
sneezes, spits or laughs releasing infected droplets, which can be inhaled by a susceptible 
person. Tuberculosis primarily causes disease in the lung but can involve any organ. In the 
immunosuppressed, TB bacilli can disseminate from the lungs to infect the brain, bones, 
kidney and other vital organs. 
Tuberculosis is a major infectious disease infecting more than one third of the world's 
population. It is estimated that between 2000 and 2020, nearly one billion people will be 
newly infected, 200 million will get sick, and 3 5 million will die from TB if control is not 
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further strengthened (WHO, 2000). It has been 50 years since the first anti-tuberculosis drug 
Table 1 
Health Indicators of Nepal 
Indicators 
Life expectancy 
Crude Birth Rate 
Crude Death Rate 
Growth Rate 
Population doubling time in years 
Infant Mortality Rate 
Under 5 Mortality Rate 
Maternal Mortality Rate 
Literacy Rate 
Male Literacy Rate 
Female Literacy Rate 
Population / Physician Ratio 
Population / Nurse Ratio 
Nepal 
57.3 years 
Male-57.1yrs, Female-57.6yrs (1999) 
35.4 per 1000 population (1997-98) 
11.5 per 1000 population (1997-98) 
2.08 % (1996) 
32(1998) 
75 per 1000 live births (1999) 
104 per 1000 live births (1999) 
150 per 100,000 live births (1999) 
52.6% (1996) 
67.9% (1996) 
37.8 % (1996) 
16,830 
4,680 
Source: Central Bureau of Statistics: Statistical Year book of Nepal, 1999 
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was discovered. Effective treatments capable of curing all patients in 6-8 months have been 
available for the last 25 years. Despite these medications, there is growing morbidity and 
mortality at the end of the twentieth century and the beginning of the twenty-first century. 
Factors contributing to the rise of TB worldwide are (1) HIV, (2) poorly managed TB control 
programs, and (3) migration (WHO, 2000). 
Tuberculosis is the leading cause of infectious disease in Nepal, where an estimated 60% 
of the adult population aged between 15-45 years are infected; 45% of the total population 
are infected and 10% of these progress to active disease. The case detection ratio in Nepal 
for TB is 50%. The patient compliance among the diagnosed cases registered for treatment is 
40% (WHO/HMG Review, 1994). Thus, half the undiagnosed and untreated cases contribute 
significantly to the spread of TB. Among diagnosed cases an estimated 60% are 
noncompliant, thus bringing about the emergence of multi-drug resistant strains of the 
bacteria and further compounding the problem. It also is no surprise that TB is once again 
increasing stigmatization among people with it, owing to the increase in drug resistant cases. 
The reasons for increased TB prevalence in Nepal can be attributed to poverty, lack of 
awareness, ineffective national TB control programs, a low case detection rate, non-
compliance with treatment, and increasing drug-resistant cases. TB patients comprise a 
significant percentage on any hospital's outpatient or inpatient population. In an 
epidemiological study of TB in a Mission hospital in Palpa district, TB ranked fourth as the 
cause for admission. Pulmonary TB was the most common type and an important cause of 
TB mortality. In the TB clinic of the hospital, 10-12 new cases were diagnosed everyday. 
The authors also identified major problems such as drug supplies at health posts not being 
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timely refurbished, a significant rate of defaulters, a low BCG vaccine coverage rate of 67%, 
poor active case finding, and the inability to trace defaulters (Bhattacharya, Bhattarai, Malla, 
Pandit, and Rajouria, 1994). A summary of the epidemiology of TB in Nepal is presented in 
Table 2. 
The following outline is a history of tuberculosis control activities in Nepal (Bam & Smith, 
1996). 
1) The pre-chemotherapy era: 1934-1950. TB sanitariums were built. These sanitariums 
were situated in high altitudes as fresh air was thought to be a significantly helpful positive. 
2) The standard chemotherapy era: 1951-1989. 
3) The Tuberculosis Control Project was established in 1965. The main aim of this project 
was to provide BCG vaccination. In the same year, 18-24 months of standard chemotherapy 
with isoniazid and thiacetazone supplemented by 3 months of streptomycin injection was 
introduced. The treatment length was later modified to a 12-month regimen. 
4) The short course chemotherapy era: 1986-1995. The discovery of Rifampicin and 
Pyrazinamide revolutionized TB treatment. It became possible to complete treatment in 6-8 
months. 
5) The Directly Observed Therapy or DOT era from 1996 to the present. 
In April 1996, four national demonstration and training centers for directly observed 
therapy were started in the Bhaktapur, Kailali, Nawalparasi, and Parsa districts. Cure rates in 
the first cohort of patients registered in these centers were 87% (Bam, 2000). In 1998, 37 
demonstration sites were established with DOT covering 17% of the population. Presently 
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Epidemiology of Tuberculosis in Nepal 
Latent Infection: 60% of population aged 15-49 
45% of the total population infected 
10% of those infected develop TB 
Incidence: 237/100,000 population (45% smear positive) 
44,000 new cases arise annually (50% detected) 
20,000 infectious or sputum positive cases every year 
75% of cases are in young adults (15-44 years) 
Low treatment completion rate (40% of those detected) 
8000-11,000 people die of TB annually 
15%) of new cases are in urban areas where 10% of the population lives 
Source: His Majesty=s Government and World Health Organization Review, 1994. 
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there are 131 treatment centers, covering over 56% of the population in 52 districts (Bam, 
2000). These centers are either health posts or primary care centers under the Ministry of 
Health. TB therapy is given under the supervision of Health Assistants and Auxiliary Health 
Workers. The goal is to gradually expand the implementation of DOT to all 75 districts by 
2003. 
Directly Observed Therapy 
Directly Observed Therapy has been hailed as the public health breakthrough of the decade 
for TB control by the WHO. For the first time since the discovery of anti-tuberculosis drugs 
in 1944 there is hope of reversing the global spread of tuberculosis. The concept of DOT 
originated from studies done in India (Madras) and Hong Kong as early as 1950 (Bayer, 
Wilkinson, 1995). However, it was not until the 1990s that supervised therapy became 
widely used, due in part to concerns about cost and the infringement on people's liberties. 
DOT is also a labor-intensive program. But DOT also appears to be the best way of ensuring 
compliance. Prior to DOT, pill counting, urine testing and making unannounced home visits 
were the only ways of trying to ensure compliance. In United States, the Advisory Council 
for the Elimination of Tuberculosis (ACET) has recommended that DOT be used in all 
locations that do not achieve a 90% treatment completion rate. This policy was enacted in 
1993 (Advisory Council for the Elimination of Tuberculosis [ACET], 1993). 
The WHO recommended DOT strategy combines five elements:(l) political commitment, 
(2) case detection through sputum smear microscopy, (3) standardized short course treatment 
for at least six to eight months, with direct observation of treatment for at least the initial two 
months, (4) regular, uninterrupted supply of anti-TB drugs, and (5) standardized recording 
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and reporting system (WHO, 2000). Once infectious cases have been detected using a 
microscope, health and community workers observe patients swallowing the correct dosage 
of anti-TB medicines. The DOT providers can be health personnel or trained people from the 
community. No hospitalization is normally required and treatment can be delivered directly to 
the patients in their community enabling them to continue working and remain with their 
families. DOT may require patients to present themselves to the health care facility at the 
required days, but DOT is also conducted in patients' homes. Anti-TB medication is given 
intermittently or daily for 6-8 months. DOT produces cure rates of up to 95% even in the 
poorest countries as seen in Peru where widespread use of DOT for more than five years has 
led to the successful treatment of 91% of cases (WHO, 2000). With TB affecting a third of 
the worlds' population, TB control by using DOT is one of the most important cost-effective 
strategies in public health today. A six-month supply of drugs for DOT costs $11(US) per 
patient in some parts of the world. The World Bank has ranked the DOT strategy as one of 
the most cost-effective health interventions (WHO, 2000). 
Related studies on Directly Observed Therapy 
Many studies have been done in developed and less developed countries to evaluate the 
effectiveness of DOT. The first study was in 1958 in Madras, India by Fox (Bayer & 
Wilkinson, 1995). Fox observed that despite patients coming from a poverty stricken 
community in a city with poor public transport (e.g., walking up to 5 miles to reach the clinic) 
it was still possible to get patients to come six days a week for streptomycin injection and a 
supervised oral dose of pyrazinamide. Thus, Fox concluded that ALong term daily supervised 
administration can be organized under special circumstances, even in developing countries 
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(Fox, 1962)." 
In a study done by Chaulk, Moore-Rice, and Rizzo (1995) an evaluation of community 
based directly observed therapy for TB control was done. The Baltimore City Health 
Department (BCHD) in 1981 implemented a community outreach strategy where DOT was 
provided at either a patient's home, workplace, school, drug treatment facility, city jail or 
nursing home. The study, which was an 11-year retrospective descriptive study, compared 
TB case rates, sputum conversion rates (SCR), rates of therapy completion and confounding 
factors such as AIDS, immigration, unemployment and poverty. DOT in Baltimore, 
Maryland, was compared with five major US cities in 1981 where TB incidence was high but 
where DOT was not used. Since 1981 when DOT was implemented, Baltimore, experienced 
the greatest decline in TB incidence among the cities compared. The rate in Baltimore 
declined from 35.6 cases per 100,000 population in 1981 to 17.2 cases per 100,000 in 1992. 
The city ranked sixth in 1981 and 28th in 1992 in the incidence of TB cases. The average TB 
incidence actually rose 2.1% in the five non- DOT comparison cities during the same period. 
Baltimore's DOT managed cases had the highest annual SCRs at 3 months (mean equaled 
90.7%) and the highest completion rates for standard anti-TB therapy (90.1%) when 
compared to the five other cities. Thus, community based DOT facilitated higher treatment 
completion rates and higher bacteriological evidence of cures. 
In a study done by El-Sadr, Medard, and Barthaud (1996) in Harlem Hospital, New York, 
DOT was found to result in a high treatment completion and visit adherence rate. Harlem had 
one of the highest TB rates in the US (221 cases per 100,000 persons as compared to 10.5 
nationwide) and a treatment completion rate of only 11%. DOT was started from 1993 and 
the program used a family model approach whereby patients were made to feel that they 
belonged to one big family with activities such as trips, birthday celebrations and various 
incentives such as certificates, clothing, meal coupons, refreshments, etc. Out of 145 TB 
cases enrolled, 95 continued with DOT. Injection drug use was reported by 46.2% of cases, 
crack cocaine use by 16.5% and 57.9% were HIV infected. Still, there was a visit adherence 
rate of 91% (the proportion of scheduled visits successfully completed within 24 hours). The 
mean sputum culture conversion took about 11 weeks. The family model approach of DOT, 
and the various incentives and enablers, could have contributed to the success of treating this 
hard to reach population. Also crucial to the success was the enthusiasm and concern of the 
staff, many of whom were themselves TB survivors. 
A study was done by Norval, San, Bakhim, Rith, Ahn, and Blanc (1998) in Cambodia to 
evaluate DOT. Cambodia has a severe TB problem with a new TB case notification rate of 
150 per 100,000 population and a TB control program established in the early 1980s 
achieving cure rates of only 40-50%. DOT was implemented in 1994 with funds from 13 
sources. The DOT strategy was initially introduced in 120 TB units in general public 
hospitals. Two and half years after the start, DOT was implemented in 85% of all public 
hospitals. In 1996 the case detection rate had reached 127 per 100,000 population for smear 
positive TB and 149 per 100,000 for all TB. Ninety percent of all TB patients receivedDOT. 
From January 1994 through June 1995,4,165 new cases had been started onDOT. Ofthese, 
89% were cured or completed treatment, 5% defaulted, 3%> died, 1% were treatment failures, 
and 2% were transferred out. The success was attributed to the strong commitment of the 
government, availability of TB drugs, hospitalization of patients during the intensive phase, 
18 
and the distribution of free food to TB patients. Thus, even in a country like Cambodia which 
has experienced genocide, war and the virtual dismantling of the health care system, DOT can 
still have a significant impact. 
Lay supervisors were shown to be equally effective DOT providers in a study done by 
Wilkinson and Davies (1997) in Hlabisa, South Africa. Since 1991 all patients with 
tuberculosis in the Hlabisa health district, South Africa have been eligible for DOT. Patients 
were supervised by either a health worker (HW), a community health worker (CHW) or a 
volunteer lay person (VLP) comprised of storekeepers. By December 1995, 2,622 patients 
had received DOT supervised by VLP (56%), HW (28%) and CHW (16%). Case holding 
declined more for HW than for either CHW or VLP. Mortality was similar and stable over 
time irrespective of the supervisor (4-6%). Thus, community-based DOT that uses an 
intermittent drug regime and volunteers as supervisors can achieve high treatment completion 
rates for TB, even in resource-poor settings. 
Burman, Dalton, Cohn, Butler, and Reves (1997) analyzed the cost-effectiveness of 
directly observed therapy versus self-administered therapy for treatment of TB. They 
concluded that despite a greater initial cost, DOT is more cost-effective because it achieves a 
higher cure rate after initial therapy and decreases treatment costs associated with failure of 
therapy and acquired drug resistance. Floyd, Wilkinson, and Gilks (1997) also compared the 
cost-effectiveness of DOT with that of conventional treatment based on study done in 
Hlabisa, South Africa. The study concluded that DOT was 2.8 times cheaper overall than 
conventional treatment ($780(US) vs $2095). 
Chowdhary, Chowdhary, Islam, Islam, and Vaughan (1997) studied TB control by community 
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health workers in Bangladesh. Bangladesh was among the first less developed nations to 
adopt DOT. In 1984, DOT was implemented with the help of the Bangladesh Rural 
Advancement Committee (BRAC), a national nongovernmental agency (NGO). This 
program started as an experiment in one sub-district or thana. By 1995 thirteen sub-districts 
were carrying out DOT. Community health workers screened villagers for chronic cough and 
collected sputum samples for acid fast bacilli. Positive patients received DOT for 12 months 
that was later modified to 8 months. The BRAC TB control program had a high rate of case 
detection and treatment compliance, with a cure rate of 85% and dropout rate of only 3.1%. 
A retrospective comparison study was done comparing patients treated with directly 
observed therapy and self-administered therapy. The setting was an urban TB control 
program in the US. The study compared treatment completion rates at 8 and 12 months after 
treatment initiation. The study concluded that patients receiving DOT were much more likely 
to complete treatment earlier (Davidson, 1998). 
Based on findings such as these, Nepal initiated DOT in 1996. This study compared TB 
patients from Bhaktapur district receiving DOT with patients receiving SAT in the same 
district, and evaluated the two programs for compliance and success rates. The various 
studies provide significant insight and possible direction. Use of voluntary lay supervisors 
as was the case in Hlabisa, South Africa may have broader implication in a country such as 
Nepal. It is also worthwhile to note that many of the DOT programs used enablers and 
incentives, an impossibility for Nepal because of the financial constraints. 
CHAPTER 3 
Methodology 
Research question 
This research was an attempt to answer the following questions. What is the rate of 
patients on DOT who completed therapy as compared to TB patients getting self-
administered therapy? What is the cure rate for patients with TB who receive DOT as 
compared to TB patients getting self-administered therapy? The effectiveness of DOT was 
compared against the conventional treatment program (self-administered therapy) which 
served as the comparison group. The study also examined the attitude of providers towards 
DOT in terms of its administration and effectiveness. 
Hypotheses 
The following hypotheses were tested: 
1) There will be no difference in patient compliance rates between patients receiving DOT 
versus those receiving self-administered therapy; 
2) There will be no difference in treatment success rates between patients receiving DOT 
versus those receiving self-administered therapy. 
Research design 
The project was a nonconcurrent cohort study. The study group were pulmonary TB 
patients who had received DOT. The comparison group were pulmonary TB patients who 
had received self-administered therapy or SAT. The information was collected from the 
National TB Center (NTC) in Thimi, where all patient records are sent. Patients in both the 
groups were active pulmonary TB cases with smear positive sputum from Bhaktapur district. 
20 
21 
The DOT patients had undergone treatment between 1997-1998. The SAT patients had 
undergone treatment between 1996-1999. As most of the SAT clinics were replaced by 
DOT, patients treated prior to 1997 were included in the SAT group to get at least 100 
patients. The clinics administering DOT and SAT were not the same. There was no random 
assignment of patients into the treatment groups. But being government run centers, the 
DOT and SAT clinics were similar in terms of staffing, size, and activities except for the 
nature of the intervention- DOT versus SAT. The clinics administering DOT and SAT were 
under the Ministry of Health with free distribution of drugs. The drugs were provided by 
donor agencies. The aim was to compare DOT and SAT interventions between TB patients 
who come from the same district or neighboring districts with similar geographic, ethnic, 
socioeconomic distribution. 
The study was retrospective in nature. Data was collected from medical records and 
included demographic variables, type of intervention, duration and outcome of the treatment. 
The DOT providers were given a questionnaire in Nepali to get feedback about the program. 
Appendix B contains the provider survey. 
The study model can be constructed as 
Xj Oi 
X 2 0 , 
where Xi represents the study group receiving DOT; X2 represents the comparison group 
receiving SAT; Oi represents the posttest for each group. 
Population and sample 
The population consisted of all diagnosed pulmonary TB patients in Nepal. The 
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investigator selected a sample of TB patients from Bhaktapur district diagnosed and treated 
between 1996 and 1999. One group of patients received DOT and the second group received 
SAT. All patients who met the following criteria were included in the study: (1) active or 
sputum positive patients from Bhaktapur district, (2) DOT patients diagnosed, registered, and 
treated between 1997-1998, (3) SAT patients treated between 1996-1999, and (4) patients 
over the age of 15. 
Only pulmonary TB was considered for the study. The reason for omitting other forms of 
TB was due to the variations in duration of treatment. Also, the intervention and drugs could 
differ by TB type. Patients younger than 15 were not included in the study as treatment in the 
pediatric age group may not be comparable to the adult group. The DOT patients were 
diagnosed and treated between 1997-1998. The SAT patients were diagnosed and treated 
between 1996-1999. They were diagnosed on the basis of sputum positive sample, chest x-
ray and clinical signs and symptoms. The clinical diagnostic criteria were as follows: (1) 
hemoptysis or spitting of blood-1 week, (2) evening rise of temperature-1 month, (3) cough-
1 month, (4) loss of weight- 1 month, and (5) loss of appetite- 1 month. The investigative 
diagnostic criteria were (1) positive sputum AFB (Acid Fast Bacilli) test, and (2) positive 
chest x-ray. The nature of treatment in both the clinics was the same and consisted of the 
following: Rifampicin, Pyrazinamide, Isoniazid and Ethambutol for two months, followed by 
Isoniazid and Ethambutol for four to six months. Total duration of treatment was six to eight 
months. 
Data collection 
Data was collected from the medical record of each patient. Records of TB patients 
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throughout the country are sent to National TB Center (NTC) in Thimi. Appendix C contains 
an example of Data collection Sheet used for each patient. Appendix D contains an example 
of patient medical record at NTC. Table 3 lists the variables that were extracted from each 
patient's medical record. The variables included descriptive measures such as demographics, 
duration and outcome of intervention. 
Dependent and Independent Variables 
The independent variables were the two interventions- DOT and S AT. The dependent 
variables included the rate of compliance and success rate. Other potentially confounding 
variables included age, gender, ethnic group, and religion. 
Data analysis 
Data was transcribed onto a computer data file and analyzed using the Statistical Package 
for the Social Sciences (SPSS). Appropriate inferential statistics, (i.e., Chi Square) were used 
to compare the study and treatment groups. Chi square test was used to compare the 
treatment success rates between the DOT and SAT group. Chi Square was also used to test 
the first hypothesis, compliance between the two groups. Tables 4 and 5 show the 
comparison between the two groups. The following comparisons were made between the 
study and control groups: (1) treatment completion rate, and (2) success or cure rate. 
Six patient outcomes were assessed within each group: (1) treatment completed, (2) 
number cured, (3) treatment discontinued, (4) treatment failure, (5) number dead during the 
course of treatment, and (6) number transferred out. Chi square analysis was done to test the 
significance of any difference. The descriptive information obtained from the provider 
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Table 3 
Study variables 
Category Variables 
Demographic Age, sex, ethnic group, religion, address 
Diagnostic Criteria Sputum status, chest x-ray 
Type of treatment DOT, SAT; length of treatment 
Outcomes Treatment success or failure 
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Table 18 
Compliance rate between DOT and SAT 
Compliance Study group DOT Comparison group SAT 
Number who complied a b 
Number that did not comply c d 
Total a+c b+d 
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Table 18 
Success or cure rate between DOT and SAT 
Cure Rate Study group DOT Comparison group SAT 
Number cured a b 
Number not cured c d 
Total a+c b+d 
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survey is described in written text. A discriminate analysis could not be done to control for 
possible confounding variables because of the very high success rates in both groups. 
Instrumentation 
The instruments used in the study were the medical records of the patients and the self-
administered questionnaire to health providers. 
Validity and reliability 
This researcher obtained data from two sources: (1) medical records, and (2) provider 
survey. Indicators for success or failure of treatment depended upon sputum test and chest x-
ray results. Thus, validity was not a limitation as these are well established indicators. The 
information on demographics was more subjective, dependent upon the health provider filling 
out the forms and the patients who provided the information. The survey questionnaire 
administered to the providers depended on their accuracy and truthfulness. This writer does 
not intend to generalize the findings of clinics in Bhaktapur with all operating clinics in Nepal. 
Confidentiality 
When collecting data, each medical record that met with criteria for the study was given a 
code number. The names of the patients were not used anywhere in the study. Only their 
ethnicity was noted. The patients were referred to by their given codes. At the end of the 
study, the code list was destroyed. The survey of providers was anonymous. They were 
told not to disclose their name, and the survey was completely voluntary. Thus, all 
reasonable safeguards were taken to ensure that patient names and provider information 
remain anonymous (See Appendix E). 
CHAPTER 4 
Results 
Description of Study Sample 
A total of 261 patients were included in the study. The DOT group consisted of 161 
patients, and the SAT group consisted of 100 patients. Patients in both groups were sputum 
positive and had positive chest x-rays at the start of treatment. All the patients were above 15 
years of age. The subjects were divided into the following age groups: 15-25, 26-35, 36-45, 
46-55, and over 55 years (Table 6). The age distribution was similar for DOT and SAT, and 
there was no significant difference between the two groups in terms of age (%2 =5.23; ns; 
df=4) (Table 7). The gender and ethnic proportions were also similar between both groups 
(Tables 8-11). The ethnic groups were divided into Brahmin, Chhetri, Newar, Tamang, and 
Others. Bhaktapur district is inhabited mostly by Newars, thus explaining the greater 
proportion of Newars in both DOT and SAT. All the patients fell into two religious groups-
Hindus and Buddhists with the majority being Hindus (Tables 12-13). There was no 
significant difference between the two groups in terms of religion (%2 =0.54; ns; df=l). 
In terms of referral, the patients fell in two main groups- National Tuberculosis Center or 
NTC and others (Tables 14-15). The category Aothers= included Bhaktapur Hospital, Patan 
Hospital, private clinics, etc. The majority, 229 out of 261 patients, had been referred from 
NTC. The proportion in each group was similar (%2 =1.6; ns; df=l). Patient outcome was 
divided into the following categories: cured, not cured, treatment discontinued, transferred, 
and death (Table 16). The last four categories were lumped together into one category of not 
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cured because of small cell sizes (Table 17). 
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Table 12 
Religion distribution of patients 
Clinic 
Age group SAT DOT Tota 
15-25 Count 36 67 103 
Expected count 38.5 64.5 103 
% within age 35% 65% 100% 
% within group 37.5% 41.6% 
26-35 Count 26 29 55 
Expected count 20.5 34.5 55 
% within age 47.3% 52.7% 100% 
% within group 27% 18% 
36-45 Count 10 29 39 
Expected count 14.6 24.4 39 
% within age 25.6% 74.4% 100% 
% within group 10.4% 18% 
46-55 Count 16 22 38 
Expected count 14.2 23.8 38 
% within age 42.1% 57.9% 100% 
% within group 16.7% 13.7% 
55+ Count 8 4 22 
Expected count 8.2 13.8 22 
% within age 36.4% 63.6% 100% 
% within group 8.3% 8.7% 
Total Count 96 161 257 
Expected count 96 161 257 
% within age 37.4% 62.6% 100% 
% within group 99.9% 100% 
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Table 7 
Chi- square test for age distribution 
Value df Sig 
Pearson Chi- Square 5.229* 4 0.256 
Likelihood Ratio 5.292 4 0.259 
Linear - by- Linear Association 0.007 1 0.934 
Number of valid cases 257 
* 0 cells have expected count less than 5. The minimum expected count is 8.22. 
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Table 12 
Religion distribution of patients 
Clinic 
Sex SAT DOT Total 
Female Count 28 37 65 
Expected count 25 40 65 
% within sex 43.1% 56.9% 100% 
% within group 28% 23.1% 25% 
Male Count 72 123 195 
Expected count 75 120 195 
% within sex 36.9% 63.1% 100% 
% within group 72% 76.9% 75% 
Total Count 100 160 260 
Expected count 100 160 260 
% within sex 38.5% 61.5% 100% 
% within group 100% 100% 100% 
Table 9 
Chi - square test of sex distribution 
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Value df Asymp. Sig. Exact sig. Exact sig. 
(2- sided) (2 sided) (1 sided) 
Pearson Chi-Square 0.780** 1 0.377 
Continuity correction* 0.542 1 0.462 
Likelihood ratio 0.773 1 0.379 
Fisher=s Exact test 0.381 0.230 
Linear by Linear Association 0.777 1 0.378 
No. of valid cases 260 
* Computed only for 2 x 2 table 
** 0 cells have expected count less than 5. The minimum expected count is 25.0. 
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Table 12 
Religion distribution of patients 
Clinic 
Ethnic group SAT DOT Total 
Brahmin Count 5 10 15 
Expected count 5.8 9.2 15 
% within ethnic 33.3% 66.7% 100% 
% within group 5% 6.2% 5.8% 
Chhetri Count 20 15 35 
Expected count 13.5 21.5 35 
% within ethnic 57.1% 42.9% 100% 
% within group 20% 9.4% 13.5% 
Newar Count 47 95 142 
Expected count 54.8 87.2 142 
% within ethnic 33.1% 66.9% 100% 
% within group 47% 59.7% 54.8% 
Tamang Count 23 31 54 
Expected count 20.8 33.2 54 
% within ethnic 42.6% 57.4% 100% 
% within group 23% 19.5% 20.8% 
Other* Count 5 8 13 
Expected count 5 8 13 
% within ethnic 38.5% 61.5% 100 
% within group 5% 5% 5% 
Total Count 100 159 259 
Expected count 100 159 259 
% within ethnic 38.6% 61.4% 100% 
% within group 100% 99.8% 99.9% 
Table 11 
Chi- Square test of ethnic distribution 
Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 7.429* 4 0.115 
Likelihood Ratio 7.294 4 0.121 
Linear- by- linear Association 0.164 1 0.686 
No of valid cases 259 
* 0 cells have expected count less than 5. The minimum expected count is 5.02. 
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Table 12 
Religion distribution of patients 
Clinic 
Religion SAT DOT Total 
Hindu Count 74 124 198 
Expected count 76.4 121.6 198 
% within religion 37.4% 62.6% 100% 
% within group 74% 78% 76.4% 
Buddhists Count 26 35 61 
Expected count 23.6 37.4 61 
% within religion 42.6% 57.4% 100% 
% within group 26% 22% 23.6% 
Total Count 100 159 259 
Expected count 100 159 259 
% within religion 38.6% 61.4% 100% 
% within group 100% 100% 100% 
Table 18 
Chi- Square test of religion distribution 
37 
Value df Asymp. Sig. Exact sig. Exact sig. 
(2- sided) (2 sided) (2 sided) 
Pearson Chi-square 0.542* 1 0.462 
Continuity correction** 0.343 1 0.558 
Likelihood Ratio 0.538 1 0.463 
Fisher=s Exact Test 0.548 0.278 
Linear by linear Association 0.540 1 0.462 
No. of valid cases 259 
** Computed only for 2 x 2 table 
* 0 cells have expected count less than 5. The minimum expected count is 23.55. 
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Table 14 
Distribution of referral clinic 
Clinic 
Referral SAT DOT Total 
NTC 
Other 
Total 
Count 91 138 229 
Expected count 87.7 141.3 229 
% within referral 39.7% 60.3% 100% 
% within group 91% 85.7% 87.7% 
Count 9 23 32 
Expected count 12.3 19.7 32 
% within referral 28.1% 71.9% 100% 
% within group 9% 14.3% 12.3% 
Count 100 161 261 
Expected count 100 161 261 
% within referral 38.3% 61.7% 100% 
% within group 100% 100% 100% 
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Table 18 
Chi- Square Test of distribution of referral clinic 
Value df Asymp. Sig. 
(2- sided) 
Exact sig. 
(2 sided) 
Exact sig. 
(2 sided) 
Pearson Chi- square 1.602* 1 0.206 
Continuity correction** 1.148 1 0.284 
Likelihood Ratio 1.663 1 0.197 
Fisher=s Exact Test 0.247 0.141 
Linear- by- linear association 1.596 1 0.206 
No. of valid cases 261 
* * Computed only for a 2 x 2 table 
* 0 cells have expected count less than 5. The minimum expected count is 12.26. 
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Table 16 
Distribution of outcome 
Clinic 
Outcome SAT DOT Total 
Cured Count 75 139 214 
Expected count 82 132 214 
% within outcome 35% 65% 100% 
Not cured Count 2 3 5 
Expected count 1.9 3.1 5 
% within outcome 40% 60% 100% 
rx discontinued Count 11 9 20 
Expected count 7.7 12.3 20 
% within outcome 55% 45% 100% 
Transferred Count 8 2 10 
Expected count 3.8 6.2 10 
% within outcome 80% 20% 100% 
Death Count 4 8 12 
Expected count 4.6 7.4 12 
% within outcome 33.3% 66.7% 100% 
Total Count 100 161 261 
Expected count 100 161 261 
% within outcome 38.3% 61.7% 100% 
Since four cells have minimum expected count of less than 5, the outcome was broadly 
divided into outcome 1 which included the cured group and outcome 2 which included not 
cured, dead, treatment discontinued and transferred. 
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Table 17 
Distribution of outcome 
Clinic 
Outcome SAT DOT Total 
Outcome 1 Count 75 139 214 
Expected count 82 132 214 
% within outcome 35% 65% 100% 
% within group 75% 86.3% 
Outcome 2 Count 25 22 47 
Expected count 18 29 47 
% within outcome 53.2% 46.8% 100% 
% within group 25% 13.4% 
Total Count 100 161 261 
Expected count 100 161 261 
% within outcome 38.3% 61.7% 100% 
% within group 100% 99.7% 
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Out of 100 patients in the SAT category, 75 were cured; that is, they had completed the 
treatment course and were sputum and chest x-ray negative. Out of 100, 25 were not cured 
(1 l=discontinued treatment, 8=transferred and lost to follow up, 4= death, 2= chest and 
sputum positive). Out of 161 patients in the DOT group, 139 were cured and 22 were not 
cured (treatment discontinued=9, transferred=2, deaths , sputum and x-ray positive=3). 
There was a significant difference between the two groups in terms of outcome, (%2 = 5.37; 
p< 0.05; df=l) (Table 18). The cure rate of the DOT group was 86.3%, while it was only 
75.0% in the SAT group. The mean treatment length was 6.8 months in the SAT group and 
7.4 months in the DOT group, a significant difference (F = 4.13; df=l, 256; p<0.05) (Tables 
19-20). The two groups also had a significant difference in the rate of compliance (%2 
-3.57; p<0.05; df=l) (Tables 21 and 22). The compliance rates were 90.2% for DOT vs 
81.8% for SAT patients. 
Tests of Hypotheses 
Hypothesis 1- There will be no difference in compliance between patients receiving DOT 
versus those receiving SAT. 
A Chi-square test was performed to compare the compliance between DOT and SAT. As 
can be seen from Tables 22 and 23, a significant difference was found in terms of compliance 
between the two groups. Thus the null hypothesis was rejected. DOT patients were more 
compliant than were SAT patients. 
Hypothesis 2 - There will be no difference in treatment success rate between patients 
receiving DOT versus those receiving SAT. 
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Table 18 
Chi-square test of patient outcome 
Test Value Df Asymp. Sig. Exact sig. Exact sig. 
(2 sided) (2 sided) (1 sided) 
Pearson Chi-square 5.368** 1 0.021 
Continuity correction* 4.628 1 0.031 
Likelihood ratio 5.238 1 0.022 
Fisher=s Exact Test 0.03 0.017 
Linear by linear association 5.348 1 0.021 
No of valid cases 261 
* Computed only for 2 x 2 table 
** 0 cells have expected count less than 5. The minimum expected count is 18.01. 
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Table 19 
Distribution of treatment length 
95% confidence interval 
For mean 
Group No. Mean Std. Std. Error Lower Upper 
Dev. Bound Bound Min Max 
SAT 98 6.831 2.4008 0.2425 6.3503 7.313 0.25 9 
DOT 160 7.3846 1.9292 0.1525 7.0833 7.685 0.03 12 
Total 258 7.1745 2.1332 0.1328 6.9130 7.436 0.03 12 
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Table 20 
Treatment leneth(ANOVA) 
Group Sum of squares df Mean squares F Sig. 
Between groups 18.581 1 18.581 4.133 0.043 
Within groups 1150.881 256 4.496 
Total 1169.462 257 
Table 21 
Distribution of compliance 
Clinic 
SAT DOT Total 
Compliant 
Non-compliant 
Total 
Count 72 
Expected count 76.7 
% within compliance 34.1% 
% within group 81.8% 
Count 16 
Expected count 11.3 
% within compliance 51.6% 
% within group 18.2% 
Count 88 
Expected count 88 
% within compliance 36.4% 
% within group 100% 
139 
134.3 
65.9% 
90.2% 
15 
19.7 
48.4% 
9.7% 
154 
154 
63.6% 
99.9% 
211 
21 
100% 
31 
31 
100% 
242 
242 
100% 
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Table 22 
Chi-square test of compliance 
Test Value df Asymp. Sig. Exact sig. Exact sig. 
(2 sided) (2 sided) (1 sided) 
Pearson Chi-square 3.573** 1 0.059 
Continuity correction* 2.857 1 0.091 
Likelihood Ratio 3.45 1 0.063 
Fishery Exact test 0.072 0.047 
Linear by Linear Association 3.558 1 0.059 
No of valid cases 242 
* Computed for 2 x 2 table 
** 0 cells have expected value less than 5. The minimum expected value is 11.27. 
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A Chi-square test was performed to compare the outcome between the two groups. As can be 
seen from Tables 18 and 19, there was a significant difference between the two groups in 
terms of outcome. Thus the null hypothesis was rejected. DOT patients had a higher 
treatment success rate than did SAT patients. 
Summary of Provider Survey 
Nine DOT providers were given questionnaire (Appendix B). The providers were as follows: 
Nursing Director (Matron)-1 
District TB Assistant-1 
Health Post In-charge (Health Assistant)-1 
Health Assistant-1 
Auxiliary Nurse Midwife (ANM)-2 
Lab Assistant-1 
Lab Technician-1 
Auxiliary Health worker-1. 
The average period of working as a DOT provider was 1 year. The average length of 
training received had been 1 week, with only one respondent saying that no training had been 
given. The training covered sputum follow-up, patient supervision, monitoring and reporting. 
One respondent said that training on health education, case detection and dispensing 
medication had been given. The lab assistants said that their training consisted of conducting 
Acid Fast Bacilli Stain, sputum smear, and giving medication. None of the providers said that 
any type of incentives were given for patients or for themselves. All the providers said that 
the medicine provided to the patients was free of cost. The providers thought that the 
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medicine was provided by the National TB Center (NTC). One provider thought that District 
Health Office, Bhaktapur supplied the drugs. All the respondents felt that DOT had improved 
the cure rate and patient compliance. All respondents said that they motivated patients by 
giving them health education. All thought that DOT should be widely implemented in Nepal 
for TB control to be effective. The reasons given were reliability, regular supply of medicine, 
short course of treatment, better follow-up, and good record keeping of patients. One 
respondent said that DOT could give rise to staffing problems. 
Chapter 5 
Conclusion 
Summary of Results 
Chi-square tests were used to compare patient compliance and treatment outcomes 
between the DOT and SAT groups. There was significant difference in patient compliance 
and outcome of treatment. Treatment length also differed between the two groups. The 
difference between the two groups in terms of outcome was significant, (%2 = 5.37; p< 0.05; 
dfM) (Table 19). The cure rate of the DOT group was 86.3%, while it was only 75% in the 
SAT group. The mean treatment length was 6.8 months in the SAT group and 7.3 months in 
the DOT group (F = 4.13; df=l, 256; p<0.05) (Tables 20 and 21). The two groups also had a 
significant difference in the rate of compliance (%2 =3.57; p<0.05; df=l) (Tables 22 and 23). 
Slightly over ninety percent of DOT patients were compliant, while 81.8% of SAT patients 
were compliant. 
Discussion 
Tuberculosis is the leading cause of death in Nepal. The threat of multi-drug resistant TB 
has added a sense of urgency to early detection and completing treatment regimens. The 
result of this study have shown that DOT was more effective compared to the SAT method. 
Even curing a single case will prevent spreading TB to many cases. Given that 45% of the 
total population is infected and 10% of these develop TB, the increase in the cure rate from 
75%i (SAT) to 86.3% (DOT) would prevent thousands of cases, if applicable to the whole 
nation. 
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A few interesting things about the patient characteristics in Nepal have been highlighted by 
this study. For example, there were more male than female patients in both the groups. This 
maybe representative of national health care utilization trends due to the lack of female 
empowerment in a less developed country like Nepal. Females are more hesitant to visit a 
medical clinic on their own. It may take up a whole day to visit the clinic. As they have to 
take care of their house and family, even one day is a lot to give up. Thus, while the rate of 
reported cases is higher for males, it may not be accurate because of under-utilization of 
health services by females. This gender behavior appears to be the opposite of utilization 
behavior in more developed countries. For example, in the United States of America, females 
report higher levels of health care utilization on several measures. Thus, this serious question 
is raised: how many cases go undetected and further spread the disease in countries such as 
Nepal. Another important observation was that all the mortality was in the over 55 age 
group. One plausible explanation is that these patients had TB for a long time and treatment 
came too late. The possibility that they could have been sputum positive cases for a long time 
is indeed very grave. 
There were no differences between the study and control groups in terms of age 
distribution, sex, religion, ethnicity, etc. Thus the two groups were comparable and did not 
appear to present any confounding variables. 
At the start of this study, DOT had already been widely implemented in Nepal. In fact, in 
the district that I had chosen, Bhaktapur, it was more difficult to find SAT cases. So this 
finding is a step in a positive direction. But there are other challenges; for example, are all 
open cases being detected? Can Nepal find the resources to continue with DOT 
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implementation, as it is a labor intensive process? Will the patients always have free drugs 
available to them? 
Limitations 
The generalizability of the results are limited because only patients in one district were 
included in the study and this sample does not represent the entire population ofNepal. There 
may also have been subjective variations on the part of clinic employees when filling out the 
medical records. 
Conclusion 
Based on the study, significant differences exist between the DOT and SAT group. Two 
conclusions can be drawn: 
(1) Patient compliance is better in DOT versus those receiving self-administered therapy; 
(2)DOT patients have a better treatment outcome than patients receiving self-administered 
therapy. 
The provider survey showed a very positive attitude among the providers towards 
DOT, which is very important for the continuation and success of DOT programs. 
However, the provider survey result should be viewed with some caution given the low 
number of providers surveyed and also given that only DOT providers were surveyed. 
Implication 
This study showed results similar to those conducted worldwide, which has shown 
DOT to be more effective in treating TB patients. This study was the first one that 
compared DOT with SAT in Nepal. The results should be encouraging to Nepalese 
government, health policy planners, donor agencies, DOT providers, and the TB patients 
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in Nepal. The results are a positive reinforcement to the donor organizations to continue 
medical and technical support to Nepal's fight against TB. Although this study showed 
DOT to be better than SAT, it also revealed that in Bhaktapur even the 75% cure rate of 
SAT was better than the national average of 40%. This outcome could be attributed to 
the close proximity of Bhaktapur with the capital Kathmandu and the National TB Center 
in Thimi. Other possible reasons include the better socioeconomic situation of inhabitants 
of Bhaktapur as a large proportion are business people and farmers. 
Recommendations 
Since DOT will soon be implemented in all treatment facilities in Nepal, long term 
plans to make it more effective, stable and lasting are needed. Such measures will mean 
better cooperation among the donors, health policy planners, providers and patients. The 
role of the providers should be given more importance through better trainings, feedbacks, 
and encouragement. Since DOT is labor intensive it may be worthwhile to consider 
training local community volunteers to administer medication and keep records. Given the 
difficult terrain of Nepal where patients have to walk all day to reach the nearest heath 
center, this approach may prove to be a very cost-effective and rewarding strategy. 
Moreover, similar examples in rural South Africa, where conditions are little different 
from those in Nepal, have shown very good results (Wilkinson et al, 1997). The 
possibility of intermittent therapy should also be reviewed. Efforts should be extended to 
make treatment less dependant on donors and medicines to be manufactured within Nepal. 
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